Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating COPD patients by gender: a post-hoc analysis in the FLAME study. (2019)

First Author: Wedzicha JA

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12931-019-0972-7

PubMed Identifier: 30621717

Publication URI: http://europepmc.org/abstract/MED/30621717

Type: Journal Article/Review

Volume: 20

Parent Publication: Respiratory research

Issue: 1

ISSN: 1465-9921